AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 4.08 |
Market Cap | 6.33M |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -10.13 |
PE Ratio (ttm) | -0.42 |
Forward PE | n/a |
Analyst | n/a |
Ask | 4.51 |
Volume | 12,174 |
Avg. Volume (20D) | 401,962 |
Open | 4.17 |
Previous Close | 4.23 |
Day's Range | 4.17 - 4.49 |
52-Week Range | 3.54 - 12.32 |
Beta | undefined |
About EVOK
Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine ...
Next Earnings Release
Analysts project revenue of $3.74M, reflecting a 123.15% YoY growth and earnings per share of -0.25, making a -96.47% decrease YoY.
2 months ago · proactiveinvestors.co.uk
Ladbrokes and William Hill owners Entain and Evoke jump on Budget reliefShares in bookmakers galloped higher after the UK Budget, led by Ladbrokes and Coral owner Entain PLC (LSE:ENT), which rose over 8%, and William Hill owner Evoke PLC, rising 12%. Paddy Power and Betfa...